Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trizivir vs Combivir + Atazanavir in Naive HIV-1
NCT00082394Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of abacavir in human immunodeficiency virus type 1 infection (HIV-1) (2 arms), sponsored by GSK. Primary endpoint: Proportion of subjects with plasma HIV-1 RNA < 50 copies/mL at 48 weeks. Started Apr 2004; status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00082394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082394.